Clinical trial
Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
NCT01504659 is registered in ClinicalTrials.gov with Juvenile Bipolar Research Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder
- Lead sponsor
- Juvenile Bipolar Research Foundation
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- July 31, 2012
- Completion date
- November 30, 2016
- Enrollment
- 5 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.